BDI reps are on-call for all your emergency and after-hours ordering. Call 1-800-948-9834
to place an order today.
BDI Pharma is a Verified-Accredited Wholesale Distributor one
of 34 active members of the HDMA, and a
member of HISCI. Always rest assured your product is being handled
with the utmost care and professionalism.
Healthcare doesn't stop with humans. See how our level of expertise has reached
the world of our special friends at www.4legPharma.com
Effective April 1, 2012 through June 30, 2012. Visit the Centers for Medicare
& Medicaid Services for more information.
|
|
NovoSeven® RT
|
Manufacturer: NovoNordisk Pharmaceuticals |
| Generic
Name: Coagulation
Factor VIIa (Recombinant),
rFVIIa
Room Temperature Stable |
| |
Indications: NovoSeven® RT is indicated for:- treatment of bleeding episodes in hemophilia A or B with inhibitors and in acquired hemophilia
- prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B with inhibitors and in acquired hemophilia
- treatment of bleeding episodes in congenital FVII deficiency
- prevention of bleeding in surgical interventions or invasive procedures in congenital FVII deficiency
|
| Product |
Size |
NDC Numbers |
PI |
MSDS |
|
NovoSeven®
RT |
1.0mg (1000ug) |
00169-7010-01 |
PI |
MSDS |
|
NovoSeven®
RT |
2.0mg (2000ug) |
00169-7020-01 |
PI |
MSDS |
|
NovoSeven®
RT |
5.0mg (5000ug) |
00169-7050-01 |
PI |
MSDS |
|
NovoSeven®
RT |
8.0mg (8000ug) |
00169-7040-01 |
PI |
MSDS |
| |
|
| Clinical Data:
For any questions or for
further information regarding NovoSeven® RT,
Coagulation Factor VIIa
(Recombinant), rFVIIa Room
Temperature Stable, clinical pharmacology, additional indications and
usages, contraindications,
warnings, precautions, adverse
reactions, dosage,
administration and/or storage
of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|